Results 221 to 230 of about 4,109,796 (295)
Scoping review of methodology for aiding generalisability and transportability of clinical prediction models. [PDF]
Ploddi K +3 more
europepmc +1 more source
Upper Cervical Cord Area as a Biomarker of Conversion to Secondary Progressive Multiple Sclerosis
ABSTRACT Objective This study assessed whether upper cervical cord area (UCCA) measured on routine brain MRI can serve as a biomarker of conversion to SPMS. Methods This is a single‐center retrospective cohort study of RRMS patients with cross‐sectional and longitudinal analyses of clinical and MRI data. Future SPMS converters were matched by age, sex,
Nabil K. El Ayoubi +8 more
wiley +1 more source
Telitacicept for IgA nephropathy: a systematic review and meta-analysis of observational studies. [PDF]
Zheng L +6 more
europepmc +1 more source
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang +23 more
wiley +1 more source
Bag size for manual ventilation during cardiopulmonary resuscitation in adult cardiac arrest: a systematic review. [PDF]
Dewan ML +4 more
europepmc +1 more source
ABSTRACT Objective Building on our prior Behavioral Risk Factor Surveillance System analysis identifying adults aged 18–39 as the primary driver of the national increase in self‐reported cognitive disability, we examined factors associated with this rise using 2013–2024 U.S. BRFSS data. Methods We analyzed U.S.
Adam de Havenon +9 more
wiley +1 more source
Artificial intelligence-based ECG as a triage tool for acute myocardial infarction: a diagnostic systematic review and meta-analysis. [PDF]
Gaelzer GC +8 more
europepmc +1 more source
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch +5 more
wiley +1 more source
Advances in antibody-mediated rejection of renal allografts. [PDF]
Song B, Sun J, Hu C, Liu X.
europepmc +1 more source

